GlaxoSmithKline Pharmaceuticals Limited India
- Detailed references
- Editorially prepared
- Download as PDF / PPT
Statista Dossier about GlaxoSmithKline Pharmaceuticals Limited India
GlaxoSmithKline Pharmaceuticals Limited was founded in 1924 in India under the name of H.J. Foster & Co. Limited. It was listed on the national stock exchange as soon as 1969. Today, it is the Indian subsidiary of GlaxoSmithKline plc located in Brentford, England and the market leader in vaccines in the private segment, along with dermal care products. Headquartered in Mumbai, Maharashtra with over 4300 employees, GSK generated a turnover of over 30 billion Indian rupees in fiscal year 2020.
This dossier underscores the key figures of the company bringing to light its background success story, whilst securing its leading position in the pharmaceutical market. Through its visionary approach in understanding and adapting to the processes underlying change, in April 2020, GSK joined forces with Sanofi in the COVID-19 vaccine development, to combat the highly communicable and life-threatening coronavirus. GSK was ranked third among global companies with a total of six COVID-drugs and vaccines in development. The last chapter highlights key figures of some of GSK’s peer competitors within the Indian market.
This dossier underscores the key figures of the company bringing to light its background success story, whilst securing its leading position in the pharmaceutical market. Through its visionary approach in understanding and adapting to the processes underlying change, in April 2020, GSK joined forces with Sanofi in the COVID-19 vaccine development, to combat the highly communicable and life-threatening coronavirus. GSK was ranked third among global companies with a total of six COVID-drugs and vaccines in development. The last chapter highlights key figures of some of GSK’s peer competitors within the Indian market.
